Loading...

Hui-Chun Irene Su

Title(s)Associate Professor, Reproductive Medicine
SchoolHealth Sciences
Phone858-657-8745
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    The Reproductive Window in Young Adult Cancer Survivors
    NIH R01HD080952Sep 16, 2014 - May 31, 2019
    Role: Principal Investigator
    Predictors of ovarian failure after chemotherapy in young breast cancer patients
    NIH K23HD058799Sep 30, 2009 - Jul 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Irene Su H, Stark S, Kwan B, Boles S, Chingos D, Ehren J, Gorman JR, Krychman M, Romero SAD, Mao JJ, Pierce JP, Natarajan L. Efficacy of a web-based women's health survivorship care plan for young breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2019 Aug; 176(3):579-589. PMID: 31054032.
      View in: PubMed
    2. Su HI, Connell MW, Bazhenova LA. Ovarian stimulation in young adult cancer survivors on targeted cancer therapies. Fertil Steril. 2016 Nov; 106(6):1475-1478. PMID: 27565250.
      View in: PubMed
    3. Su HI, Flatt SW, Natarajan L, DeMichele A, Steiner AZ. Impact of breast cancer on anti-mullerian hormone levels in young women. Breast Cancer Res Treat. 2013 Jan; 137(2):571-7. PMID: 23224236.
      View in: PubMed
    4. Su IH, Chen YC, Hwang WT, Liu Z, Su TP, Chen TJ, Barnhart KT, Yang YX. Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause. 2012 Aug; 19(8):931-41. PMID: 22453198.
      View in: PubMed
    5. Su HI, Schreiber CA, Fay C, Parry S, Elovitz MA, Zhang J, Shaunik A, Barnhart K. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides. Contraception. 2011 Nov; 84(5):525-32. PMID: 22018129.
      View in: PubMed
    6. Su HI, Chung K, Sammel MD, Gracia CR, DeMichele A. Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors. Fertil Steril. 2011 Apr; 95(5):1857-9. PMID: 21193192.
      View in: PubMed
    7. Su HI. Measuring ovarian function in young cancer survivors. Minerva Endocrinol. 2010 Dec; 35(4):259-70. PMID: 21178920.
      View in: PubMed
    8. Su HI, Sammel MD, Springer E, Freeman EW, DeMichele A, Mao JJ. Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat. 2010 Nov; 124(1):205-11. PMID: 20182796.
      View in: PubMed
    9. Su HI, Sammel MD, Green J, Velders L, Stankiewicz C, Matro J, Freeman EW, Gracia CR, DeMichele A. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer. 2010 Feb 01; 116(3):592-9. PMID: 19918920.
      View in: PubMed